Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05681403	Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma	not yet recruiting	N/A	53	First Affiliated Hospital Xi'an Jiaotong UniversityOTHER	1	Jan 12, 2023	clinicaltrials
NCT05298293	Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma(EMILY)	not yet recruiting	N/A	160	WepromOTHER	1	Apr 5, 2022	clinicaltrials